VACCINE NARRATIVE POPSDEP BRIEFING 15FEB91

File: 102996_sep96_decls11_0001.txt
Page: 0001
Total Pages: 2

Subject: VACCINE NARRATIVE POPSDEP BRIEFING  15FEB91                     

Unit: OTSG        

Parent Organization: HSC         

Box ID: BX003202

Folder Title: UPDATE ON THE MEDICAL BIOLOGICAL WARFARE -BW- DEFENSE PROGRAM                                   

Document Number:          2

Folder SEQ  #:         22




                                    UNCLASSIFIED






                                 VACCINE NARRATIVE
                            OPSDEP BRIEFING, 15 FEB 91

        Ted, please change slide 3 (ANTHRAX VACCINE PRODUCTION). Change
        under Michigan              EMembers" to               Merabers".
        Reason is that the FDA has not approved the two fermentors. Also,
        one of the new fermentor malfunctioned and is being repaired.
        Will provide update as soon as get good idea of status.

        So slide is as follows:


        ANTHRAX VACCINE PRODUCTION


        MICHIGAN
                                  28 FEB 91
                                     MAR 91



        rest of slide






        SLIDE 1. VACCINE SHIPPED. To date there have been three
        shipments of vaccines and botulinum antitoxin shipped to the AOR.
        Enough vaccines have been delivered to vaccinate the number of
        service members listed on the slide. The latest information
        indicates that CENTCOM is progressing well with the vaccination
        program.

        SLIDE 2. CENTCOM CONTINGENCY STOCKS (AFTER EXPOSURE) One of the
        major points of the Medical Biological Warfare Action Plan is to
        provide for the treatment of service members after an exposure to
        anthrax or botulinum toxin. As a result, a CENTCOM Contingency
        stock of anthrax vaccine and botulinum antitoxin was established
        for post-exposure treatment as listed on the slide. If service
        members (SM) are exposed to anthrax, they would be immediately
        directed by their commander to begin taking the Cipro antibiotic.
        Then as the situation permits, the SM would complete the three
        dose anthrax treatment vaccination series. Because of the small
        quantities of the botulinum antitoxin, it will have to be used
        prudently for SM's exposed to the botulinum toxin. Currently
        there is enough Cipro in the AOR to treat @seritice members for
        Odaya.

    SLIDE 3. ANTHRAX VACCINE PRODUCTION The projected anthrax
        vaccine production for the three manufacturers is listed on the
        slide.


        CIASSIFIED BY: MULTIPLE SOURCES
        DECIASSIFY ON: OADR
       DECLASSIFIED
       ON: 16 OCT 96                                UNCLASSIFIED
       BY: SEC ARMY (DAMH) UNDE                2958

Document 2 f:/Week-36/BX003202/UPDATE ON THE MEDICAL BIOLOGICAL WARFARE -BW- DEFENSE PROGRAM/vaccine narrative popsdep briefing 15feb91:10259613063412
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003202
Unit = OTSG
Parent Organization = HSC
Folder Title = UPDATE ON THE MEDICAL BIOLOGICAL WARFARE -BW- DEFENSE PROGRAM
Folder Seq # = 22
Subject = VACCINE NARRATIVE POPSDEP BRIEFING 15FEB91
Document Seq # = 2
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 25-OCT-1996